This August’s profit reporting has produced some big market movers with the tech sector once again shining, despite much talk from within the sell-side broker and retail investment advisory community that the resources sector was the place to be.
However, shares in the likes or mining giants BHP Billiton Limited (ASX: BHP) and Rio Tinto Limited (ASX: RIO) have actually fallen over the past month, while the likes of WiseTech Global Ltd (ASX: WTC) and AfterPay Touch Group Ltd (ASX: AFT) have gone gangbusters.
But they’re not the only ones to do well, so let’s take a quick look at three more stars from profit reporting season and consider whether they have more gas in the tank.
CSL Limited (ASX: CSL) A standout result came from healthcare giant CSL which has gained around 15% since handing in a full year profit 29% above the prior year at $1.73b and ahead of analysts’ average estimates. At $102 billion it’s now worth more than all the banks except CBA and boasts stronger long term growth prospects. CSL is forecasting 10%-15% profit growth in FY 2019.
Surprisingly, I was able to pick up more shares for $202.50 on the day it reported, with the stock now looking priced for perfection at $227.80 a couple of weeks later. This is a business that should be in every ASX investor’s portfolio, but I would not pay anymore than today’s valuation for shares.
Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) is another impressive healthcare business that has produced 13% share price gains this August. Its financial year ends on March 31 2019, but on August 23rd it upgraded guidance for its profit to now come in around $NZ95 million on revenue of NZ$295 million for the six months ending September 30 2019. It’s also now expecting full year profit of NZ$215 million partly thanks to a softer NZ dollar. In fact the NZ dollar is sinking, which is why Fisher & Paykel hit a record high today, with room to go higher in my opinion.
Bapcor Limited (ASX: BAP) is a business I tipped to impress this August and its 32% pro forma net profit growth did not disappoint. Bapcor remains a well run business producing growth via acquisitions and organically via solid operational performance. It’s forecasting profit growth of 9% to 14% in FY 2019 which may turn out to be conservative if the cards drop nicely. Although, I already own the stock, I wouldn’t hesitate to add to my position at a record high price of $7.45 today.
We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.
That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Atlassian.
We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!
You can find Tom on Twitter @tommyr345
The Motley Fool Australia owns shares of and has recommended Bapcor. The Motley Fool Australia owns shares of AFTERPAY T FPO, Appen Ltd, and WiseTech Global. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.